Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Total Non-Current Liabilities (2016 - 2025)

Qiagen (QGEN) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 84.3% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 84.3% year-over-year, with the annual reading at $2.0 billion for FY2025, 84.3% up from the prior year.
  • Total Non-Current Liabilities hit $2.0 billion in Q4 2025 for Qiagen, up from $1.1 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.0 billion in Q4 2025 to a low of $1.1 billion in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2021.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 38.67% in 2021 and later skyrocketed 84.3% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $1.5 billion in 2021, then rose by 20.46% to $1.8 billion in 2022, then tumbled by 33.49% to $1.2 billion in 2023, then decreased by 12.04% to $1.1 billion in 2024, then surged by 84.3% to $2.0 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for QGEN at $2.0 billion in Q4 2025, $1.1 billion in Q4 2024, and $1.2 billion in Q4 2023.